Next Article in Journal
Shock-Associated Systemic Inflammation in Amniotic Fluid Embolism, Complicated by Clinical Death
Previous Article in Journal
Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathophysiology
Volume 30
Issue 1
10.3390/pathophysiology30010005
pathophysiology-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Supplementation with Resveratrol Attenuates Serum Melatonin Level, Pro-Inflammatory Response and Metabolic Disorder in Rats Fed High-Fructose High-Lipid Diet under Round-the-Clock Lighting

by
Yurii Frenkel
1,
Valerii Cherno
1,
Heorhii Kostenko
2,
Hitesh Chopra
3,
Rupesh K. Gautam
4,* and
Vitalii Kostenko
2,*
1
Department of Anatomy, Clinical Anatomy, Operative Surgery, Pathomorphology and Forensic Medicine, Petro Mohyla Black Sea National University, 54000 Mykolayiv, Ukraine
2
Department of Pathophysiology, Poltava State Medical University, 36011 Poltava, Ukraine
3
Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India
4
Department of Pharmacology, Indore Institute of Pharmacy, Rau, Indore 453331, India
*
Authors to whom correspondence should be addressed.
Pathophysiology 2023, 30(1), 37-47; https://doi.org/10.3390/pathophysiology30010005
Submission received: 28 December 2022 / Revised: 16 February 2023 / Accepted: 16 February 2023 / Published: 19 February 2023
Browse Figure
Versions Notes

Abstract

:
This study aims to investigate the effect of resveratrol on systemic inflammatory response and metabolic disorder in rats fed a high-fructose high-lipid diet (HFHLD) and exposed to round-the-clock lighting (RCL). 21 adult male Wistar rats were randomly divided into 3 groups: control (group 1, n = 7); HFHLD for 8 weeks + round-the-clock lighting (RCL) (group 2, n = 7); HFHLD + RCL + Resveratrol (in a daily dose of 5 mg/kg intragastrically (group 3, n = 7). Results show that the combined effect of HFHLD and RCL reduces the serum melatonin (p < 0.001) and accelerates pro-inflammatory activities, oxidative stress, and metabolic disorder. There is a significant increase in the serum tumour necrosis factor-alpha (TNF-α) and C-reactive protein (CRP) (both p < 0.001), blood malondialdehyde—thiobarbituric acid adducts (MDA-TBA2) (p < 0.001), serum glucose (p < 0.01), insulin concentration, and the homeostatic model assessment insulin resistance (HOMA-IR) index (both p < 0.001), serum with very low-density lipoprotein (VLDL), and triacylglycerol (TAG) (both p < 0.001). At the same time, the decrease in the serum high-density lipoprotein (HDL) level (p < 0.001) is observed in the HFHLD + RCL group compared to the control. In the HFHLD + RCL + Resveratrol group, hypomelatonaemia (p < 0.001), pro-inflammatory actions, oxidative stress, and metabolic disorder were mitigated. Resveratrol can cause a significant rise in the serum melatonin and reduce serum TNF-α and CRP levels (both p < 0.001), blood MDA-TBA2 (p < 0.001), serum glucose (both p < 0.01), insulin concentration, and HOMA-IR (both p < 0.001), serum VLDL and TAG (both p < 0.001) compared to the group 2, while serum HDL level increases (p < 0.01). Resveratrol attenuates pro-inflammatory responses and prevents considerable metabolic disorder in rats fed HFHLD under RCL.

1. Introduction

Substantial changes in the daily light-dark cycle can result in the disorganisation of the circadian system, including melatonin rhythm alterations. The relevance of this issue is conditioned by the changes reshaping the sleep/work cycle in industrialised countries and the growing tendency to a night work regime with the rise in the exploitation of visual display units, smartphones, and light-emitting diode lighting that cause a shift in the light spectrum toward artificial lighting sources [1].
In the long term, light-dependent disorganisation of the circadian system appears to be very detrimental to health. A number of epidemiological studies have shown that under these conditions there is a significant increase in rates of several diseases, including metabolic syndrome, type 2 diabetes, obesity, cardiovascular diseases, mood disorders, cancer, and age-related risks [2,3,4]. Voluminous experimental and clinical studies evidence the role of hypomelatonaemia in the mechanisms contributing to the development of carbohydrate and lipid metabolic disorders, systemic inflammation, endothelial dysfunction, and nitro-oxidative stress [5].
In our opinion, these disorders can vary considerably under the combined impact of light-dependent disorganisation of the circadian system and diet. Recent reports demonstrate the impact of diets on serum melatonin and its circadian fluctuation. For instance, the capability of certain concentrations of caffeine and alcohol, as well as deficiency of some nutrients (folate, magnesium, and zinc), to reduce the nocturnal production of melatonin, but this effect is minor compared with the light–dark cycle [6].
Our more recent studies on rats have proven that the melatonin concentration in the blood serum can considerably decrease under combined exposure to round-the-clock lighting (RCL) and a high-fructose high-lipid diet (HFHLD) for 60 days [7]. The administration of melatonin under this condition partly lessens the manifestation of carbohydrate and lipid metabolism disorders and signs of nitro-oxidative stress in the skeletal muscles and the liver of rats, though a homeostatic model assessment insulin resistance (HOMA-IR) index under this condition demonstrates no significant changes [8]. It is evident that under these conditions the normalisation of the melatonin level is not sufficient to correct metabolic disorder, which can be achieved by suppressing the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) or by inducing the nuclear-factor-E2-related factor-2 (Nrf2), antagonistic to NF-κB [9,10]. The best safety profile among agents that can inhibit NF-κB and/or activate Nrf2 is found in plant polyphenols, particularly in bioflavonoids, epigallocatechin-3-gallate [11,12], and quercetin [13,14].
Resveratrol (3,4′,5-trihydroxy-trans-stilbene), a natural phytoalexin, is also able to concurrently suppress NF-κB and activate Nrf2–antioxidant response element (ARE) signalling pathway [15,16], alleviate NF-κB-dependent pro-inflammatory hypercytokinaemia and endothelium dysfunction (in higher degree compared to quercetin) [17], and, in combination with melatonin, enhances antioxidant activity and decreases gene expression of the insulin-regulated glucose transporter GLUT4, sirtuin 1 (SIRT1) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) in heart tissue in a diabetic aged rat model [18].
Given that the role of transcriptional factors NF-κB and Nrf2 is associated with modifying the mammalian circadian clock [19,20], it seems important to focus on the capability of resveratrol to modulate serum melatonin levels under the co-effect of RCL and HFHLD. Another reason to carry out this study is to investigate the effect produced by resveratrol on the systemic inflammatory response and carbohydrate and lipid metabolism under the combined action of the circadian system disorganisation and “western diet”, considering the fact that efficacy of specific NF-κB inhibitor ammonium pyrrolidine diothiocarbamate or Nrf2 inducer dimethyl fumarate is limited because of their toxicity [9,10].
Therefore, this study aims to investigate the effect of resveratrol on serum melatonin levels, systemic inflammatory response, and metabolic disorder in rats fed a HFHLD and exposed to RCL.

2. Materials and Methods

2.1. Chemicals

Crystalline D-Fructose (≥99.5%, Ph. Eur.) was purchased from ADM, Turkey, while resveratrol (3,4′,5-Trihydroxy-trans-stilbene,5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3- benzenediol, ≥99%)was obtained from Merck Life Science, Poland. Diagnostic kits for determining insulin, tumour necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) in the blood serum were purchased from MyBioSource.com, USA. Analytical kits for measuring glucose and assessing the lipid profile in the blood serum were procured from Filisit-Diagnostics, Ukraine.

2.2. Experimental Subjects

The 21 adult male Wistar rats (weight: 235 ± 20 g) used for this study were bred in an experimental biological clinic (vivarium) at the Petro Mohyla Black Sea National University, Mykolayiv, Ukraine. The animals were kept under standard environmental conditions (air temperature: +22 ± 2 °C, air humidity: 30–60%). The animals had free access to water and rodent pellets. Prior to the commencement of the study, bioethical approval was obtained from the Commission on Bioethics of Petro Mohyla Black Sea National University, Mykolayiv, Ukraine.

2.3. Experimental Design

The rats were randomly divided into 3 groups: control (group 1, n = 7); High-Fructose High-Lipid Diet (HFHLD) + round-the-clock lighting (RCL) (group 2, n = 7); HFHLD + RCL + Resveratrol (group 3, n = 7). Group 1 was fed standard chow (Table 1) and kept on a 12/12 h light/dark cycle. Group 2 waskept on a HFHLD for 8 weeks and exposed to RCL. Group 3 received resveratrol in a daily dose of 5 mg/kg [21] intragastrically. Resveratrol was administered together with carbohydrates (20% aqueous solution of fructose) whichincreased the solubility and bioavailability of stilbenoids [22]. Rats fromthe first two groups, instead of receiving resveratrol, were given 1 mL of a 20% solution of fructose intragastrically as a “placebo”.
The rats were kept on a HFHLD for 2 months: the animals received a 20% aqueous solution of fructose for drinking and ahigh-lipid diet, whose components and content are given in Table 1. Fromthe 30th day of the experiment, the rats were exposed to RCL with an intensity of 1500 lx over the next 30 days, as previously reported [23].
After the experiment, the rats were sacrificed under thiopental anaesthesia in the morning (8.00–10.00), minimizing the effect of daily fluctuations in pineal melatonin secretion. The animals were given thiopental sodium (50 mg/kg, intraperitoneally, manufacturer: Kyivmedpreparat, Arterium Corporation, Kyiv, Ukraine). After that, they were dissected, and blood was taken via cardiac puncture sample bottles containing lithium heparin (30 IU per 1 mL of blood) (article LG3902, obtained from Sky Medica, Kyiv, Ukraine). Then heparinised blood was centrifuged (3000× g, 15 min) at room temperature. Each sample’s separated top layer of serum was used for the analysis.

2.4. Biochemical and Enzyme-Linked Immunosorbent Assays

To assess the serum melatonin levels, TNF-α, CRP, and insulin we used highly sensitive and specific ELISA kits for rat samples. Optical density readings were taken with awavelength of 450 nm (Stat Fax 2100 Microplate Reader, Awareness Technology, Inc., Palm City, FL, USA).
To measure secondary products of lipid peroxidation (LPO) in the blood—malondialdehyde (MDA)—thiobarbituric acid (TBA) adducts (MDA-TBA2) with maximum light absorption of 532 nm, we used a spectrophotometer ULAB 101 (China). A rise in their concentration after 1.5 h incubation in a pro-oxidant ascorbate-iron buffer (pH = 7.4; 1 litre of the buffer contained 1.9 g tris-(2-hydroxy-methyl)-aminomethane hydrochloride, 50 mL 0.1 N HCl, 1.4 g ascorbic acid, and 32 mg FeSO4 × 7H2O) and was used to measure the general antioxidant blood potential (the ability of the blood to resist LPO under the aggressive pro-oxidant environment) [24].
Serum glucose, total cholesterol (CH), high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), and triacylglycerol (TAG) concentrations were measured using enzymatic methods employing photometric equipment for measuring the optical density of materials that can measure the optical density of solutions at a wavelength of 490–600 nm (spectrophotometer ULAB 101, China) and standard laboratory reagent kits.
Insulin resistance was assessed by the homeostatic model assessment insulin resistance (HOMA-IR) index using the equation: HOMA-IR = fasting glucose (mmol/L) × fasting insulin (μU/mL)/22.5 [25].

2.5. Statistical Analysis

The findings were statistically analysed using the Microsoft Office Excel software package with the Real Statistics 2019 extension. We exploited the Shapiro-Wilk test to verify the normality of variances. The arithmetic mean and standard error of mean (SEM) were computed. The results are presented as mean ± SEM. Assuming that all samples had a normal distribution, we used the parametric analysis of variance (ANOVA), which was followed by a pairwise comparison of groups using the Student’s t-test for independent samples and Tukey’s honestly significant difference analysis. Multiple comparisons were avoided by employing the Dunn—Šidák correction. p < 0.05 was used to determine whether the differences between the arithmetic means were significant.

3. Results

3.1. Effects of Resveratrol on the Melatonin Level in the Serum of the Rats Fed a High-Fructose High-Lipid Diet under Round-the-Clock Lighting

Under the combined effect of RCL and HFHLD, the serum melatonin concentration significantly decreased by 4.5 times, achieving 7.1 ± 0.7 pg/mL (p < 0.001) (Figure 1). The dietary supplementation with resveratrol under RCL and HFHLD resulted in the growth of the melatonin level, which was 1.9 times higher than the respective values in group 2 (p < 0.001).

3.2. Effects of Resveratrol on the Systemic Inflammatory Response Indices in the Serum of Rats Fed a High-Fructose High-Lipid Diet under Round-the-Clock Lighting

The animals exposed to RCL and kept on HFHLD demonstrated considerable deterioration of systemic inflammatory response indices, such as serum concentrations of the TNF-α, a pro-inflammatory cytokine, CRP, and an acute phase reactant (Table 2).
The serum TNF-α and CRP levels in rats with RCL and HFHLD were 3.2-fold and 3.1-fold higher, respectively, than in the control animals (both p < 0.001).
The administration of resveratrol during the RCL and HFHLD combined exposure led to a statistically significant reduction in the TNF-α and CRP concentration by 2.5 and 2.4 times, respectively, compared to the results in group 2 (both p < 0.001).

3.3. Effects of Resveratrol on Lipid Peroxidation in the Blood of Rats Fed a High-Fructose High-Lipid Diet under Round-the-Clock Lighting

Simultaneous action of the RCL and HFHLD was accompanied by the changes in LPO and general antioxidant blood potential in the rats’ blood (Table 3). When compared to the corresponding values in the control group, the MDA-TBA2 concentration under RCL and HFHLD nearly doubled: it grew 2.1-fold before the incubation and 1.9-fold after the incubation (both p < 0.001). The MDA-TBA2 increment throughout incubation in the pro-oxidant buffer solution was 1.8 times higher than the results in the control rats (p < 0.01), indicating a significant decline in general antioxidant blood potential.
Resveratrol administered under RCL and HFHLD lowered the MDA-TBA2 level in the blood by 1.8 times (before incubation) and by 1.7 times (after incubation) in comparison to the group 2 values (both p < 0.001). The MDA-TBA2 increment over incubation in a pro-oxidant buffer solution was 1.7 times less than the respective values in group 2 (p < 0.01), which evidences the growth in general antioxidant blood potential under the dietary supplementation of resveratrol.

3.4. Effects of Resveratrol on Carbohydrate Metabolism in the Serum of Rats Fed a High-Fructose High-Lipid Diet under Round-the-Clock Lighting

The animals exposed to RCL and kept on HFHLD demonstrated considerable deterioration of carbohydrate metabolism (Table 4). There was a 1.4-fold difference between the serum glucose levels and the corresponding values in group 1 (p < 0.01). The serum insulin concentration and HOMA-IR were 3.7 times higher compared to the control group (both p < 0.001).
Resveratrol administered under RCL and HFHLD combination reduced the glucose level, which was 1.5 times inferior to the result in group 2 (p < 0.01). In comparison to the results in group 2, the serum insulin level and HOMA-IR fell 2.6 and 2.8 times, respectively (both p < 0.001).

3.5. Effects of Resveratrol on Lipid Profile in the Serum of Rats Fed a High-Fructose High-Lipid Diet under Round-the-Clock Lighting

The animals, when exposed to RCL and receiving HFHLD, demonstrated a considerable 2.7-fold fall in serum HDL compared to the respective value in the control rats (p < 0.001) (Table 5). On the other hand, VLDL and TAG levels considerably rose and were 3.3 and 3.2 times higher than in group 1, respectively (both p < 0.001).
The HDL concentration was increased by dietary resveratrol supplementation under RCL and HFHLD combination and was 2.1 times higher than the results in group 2 (p < 0.01). When compared to the results in group 2, the levels of VLDL and TAG decreasedby1.9 times for each (both p < 0.001).

4. Discussion

Earlier, we demonstrated that the development of hypomelatoninaemia naturally occurs in rats due to long-term RCL exposure and does not manifest when the rats are kept on HFHLD. However, when these factors act together, the melatonin level is significantly reduced compared to the effects resulting from the separate use of the above-mentioned factors [7]. This confirms the ability of alimentary factors under certain conditions to influence melatonin secretion, which was discovered by other researchers [3]. Dietary components such as glucose, sodium, ethanol, and caffeine have been shown to affect circadian rhythms and melatonin production by altering the expression of circadian oscillator proteins [3]. We can presume that other carbohydrates (besides glucose) and lipids are also capable of reducing pineal melatonin production through similar mechanisms.
It is noteworthy that the dietary supplementation with resveratrol over RCL and HFHLD significantly elevated the serum melatonin level compared with the findings of group 2. Earlier studies on the diabetic-aged rat model demonstrated that the effect of resveratrol and melatonin administered separately and their combination could increase SIRT1 gene expression in heart tissue [18] that can lead to the reduction of the activity of several pro-inflammatory and pro-oxidant transcription factors, such as NF-κB, STAT3, FOXO, and p53 [26]. The NF-κB suppression restricts the transcription of the crucial enzyme in pineal melatonin synthesis—arylalkylamine N-acetyltransferase [27]. This points out that resveratrol can be considered as both an inducer of melatonin synthesis and a compound that has a synergic impact along with this hormone on the immune system and metabolism due to their effects on the same transcription factors.
Some studies have revealed the association between systemic inflammatory response and diets rich in fructose [28] and fats [29]. For instance, fructose intake increases the pro-inflammatory cytokines, intestinal permeability, and lipid accumulation in the liver, and increases pro-inflammatory cytokines [28]. Elevated free fatty acids and cytokines can activate the inhibitory kappa B kinase (IKK) complex and NF-κB both through activating Toll-like receptors and through inducing cellular stresses (oxidative or/and endoplasmic reticulum) [29]. High fructose consumption can activate NF-κB via sphingosine kinase 1/sphingosine-1-phosphate induction [30]. Excessive lighting in the dark phase leads to the perturbation of clock genes (CLOCK, PER1, PER2) in humans and rodents by increasing immune activation and producing pro-inflammatory cytokines, even in the absence of immune challenge [31,32]. Some proteins of the circadian oscillator, and, in particular, CLOCK, are known to be involved in the NF-κB activation [33].
In fact, according to our findings, the rats exposed to RCL and kept on HFHLD demonstrated an increase in TNF-α and CRP, which are markers of the systemic inflammatory response. The obtained results on the statistically significant reduction in the serum TNF-α and CRP under RCL and HFHLD under the resveratrol administration are supported by the data from randomised controlled trials according to which dietary supplementation with resveratrol dramatically decreased TNF-α and CRP levels [34]. Resveratrol is supported as an adjuvant to pharmacologic therapy of metabolic disorders, significantly improving inflammatory markers.
Previously we have found out that the simultaneous effect of RCL and HFHLD leads to more marked metabolic disorders, such as LPO, and a decrease in the general antioxidant blood potential in the blood of rats, hyperinsulinaemia, hypo-α-lipoproteinaemia, hypertrialcylglycerolaemia, and increased visceral fat mass, in comparison with the animals kept on the HFHLD only [7]. This study demonstrated that resveratrol administered under RCL and HFHLD reduces the MDA-TBA2 level and its increment over 1.5-h incubation in pro-oxidant ascorbate-iron buffer that points out the LPO restrain and growth in general antioxidant blood potential. It has been suggested that the strong antioxidant properties of resveratrol allow it to reduce oxidative stress and inhibit free radicals, especially those produced by LPO. The findings of this study are consistent with other published results, which demonstrated that rats fed with various levels of resveratrol had decreased serum LPO products. For instance, 4-month supplementation of 0.04% and 0.06% resveratrol significantly lowered MDA concentration in the serum of rats fed high fructose diet (63%) [35]. A 10-week resveratrol diet supplementation (at a daily dose of 30 mg/kg·bw) significantly decreased hepatic MDA, improved its superoxide dismutase and catalase, and reduced glutathione values in rats fed HFHLD; additionally, serum total antioxidant capacity was insignificantly affected compared to the HFHLD group [36]. Resveratrol is known as an antioxidant exerting a dual effect: it can increase the activity of antioxidant enzymes (manganese-containing superoxide dismutase, catalase, glutathione peroxidase, glutathione S-transferase, and glutathione reductase) and can act as a scavenger of superoxide, hydroxyl and other free radicals that prevents LPO in cell membranes and DNA lesions [37]. It is known that the expression of the genes encoding the aforementioned antioxidant enzymes is associated with the activation of the Nrf2–ARE by resveratrol [38].
Under RCL, the antioxidant effect of resveratrol can also be associated with its capability, discovered in this study, to increase serum melatonin levels. This hormone, known for its direct antiradical properties [39], promotes the expression of a number of antioxidant enzymes (superoxide dismutase, glutathione peroxidase) [40].
The dietary supplementation with resveratrol under RCL and HFHLD produces sufficient impact on carbohydrate and lipid metabolism under the experimental conditions by lowering serum glucose and insulin, HOMA-IR, as well as serum VLDL and TAG, and increasing HDL level compared with the findings in group 2.
Our results correspond with data on the effect of resveratrol on carbohydrate and lipid metabolism, demonstrated under long-term resveratrol administration. Thus, resveratrol considerably improves the lipid profile (significantly declines the VLDL and TAGs concentrations, normalizes CH and LDL levels, and increases the HDL level), insulin sensitivity, and hepatic mRNA expression of peroxisome proliferator-activated receptor alpha (PPARα), and diminishes hepatic NF-κB and morphological characteristics of liver steatosis [36]. The role of disorganisation of the circadian system in the mechanisms of metabolic disorders is confirmed by the data on the capability of resveratrol to abolish 11-week high-fat diet-induced circadian desynchrony and ameliorate the impaired lipid profiles, the plasma leptin rhythmities in mice that, as we suggest, can be associated with its impact on the expression of clock genes (BMAL1, CLOCK, and PER2) and clock-controlled lipid metabolism-related genes (SIRT1, PPARα, SREBP-1c, ACC1, and FAS) [41].
Obviously, the mitigation of pro-inflammatory responses and metabolic disorder under the combined pathogenic impact of a high-calorie carbohydrate-lipid diet and light-dependent disruption of the biological clocks results from the effect caused by resveratrol on key signalling pathways involved in the regulation of immune response, inflammation, oxidative stress, carbohydrate and lipid metabolism, and circadian oscillator. This multidirectional action of resveratrol favourable distinguishes it from other polyphenols.
We are aware of some limitations in this study. The rat model is not a complete simulation of the pathological processes in patients who experience the pathogenic effects of the western lifestyle, particularly a high-calorie carbohydrate-lipid diet, and light-dependent disruption of the biological clocks. Therefore, additional clinical data are required to support the results so far. Since this study investigated the effects of resveratrol under the combined action of two factors (HFHLD and RCL), which can cause more pronounced inflammatory and metabolic disorders, as shown in our previous paper [7], the assessment of effects produced by resveratrol under separate action of these factors requires special experimental design, including additional control groups. Moreover, the measurement of serum melatonin in the morning does not reveal the regularities of its circadian rhythmicity in rats during the experiment. Determining the MDA-TBA2 increment over the blood incubation in pro-oxidant buffer solution evaluated only the general antioxidant blood potential regardless of the contribution from enzymatic and low-molecular antioxidant compounds that requires further in-depth investigation.

5. Conclusions

The administration of resveratrol considerably restrains the fall of serum melatonin, reduces serum TNF-α and CRP levels, blood MDA-TBA2, serum glucose and insulin concentrations, HOMA-IR, serum VLDL, and TAG levels, increases serum HDL, and thereby prevents pro-inflammatory activities, LPO and metabolic disorder, as well as improving general antioxidant blood potential in rats fed a high-fructose high-lipid diet under round-the-clock lighting.

Author Contributions

Conceptualization, Y.F. and V.K.; Data curation, Y.F.; Formal analysis, Y.F. and H.K.; Investigation, Y.F.; Methodology, V.K.; Project administration, V.C.; Resources, Y.F. and V.C.; Supervision, V.K.; Writing—original draft, Y.F.; Writing—review & editing, Y.F., V.C., H.K., V.K., H.C., and R.K.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Institutional Review Board Statement

The study was conducted in accordance with the requirements of the European Convention for the protection of vertebrate animals used for research and other scientific purposes (Strasbourg, 1986) and approved by the Commission on Bioethics of Petro Mohyla Black Sea National University, Mykolayiv, Ukraine. The experiment complied with the requirements of the European Union Directive 2010/10/63 EU on animal experiments.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blume, C.; Garbazza, C.; Spitschan, M. Effects of light on human circadian rhythms, sleep and mood. Somnologie 2019, 23, 147–156. [Google Scholar] [PubMed] [Green Version]
  2. Touitou, Y.; Reinberg, A.; Touitou, D. Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: Health impacts and mechanisms of circadian disruption. Life Sci. 2017, 173, 94–106. [Google Scholar]
  3. Arango, C.; Buitelaar, J.K.; Fegert, J.M.; Olivier, V.; Pénélaud, P.-F.; Marx, U.; Chimits, D.; Falissard, B.; Barylnik, J.; Birdeanu, L.; et al. Safety and Efficacy of Agomelatine in Children and Adolescents with Major Depressive Disorder Receiving Psychosocial Counselling: A Double-Blind, Randomised, Controlled, Phase 3 Trial in Nine Countries. Lancet Psychiatry 2022, 9, 113–124. [Google Scholar] [PubMed]
  4. Shkodina, A.D.; Tan, S.C.; Hasan, M.M.; Abdelgawad, M.; Chopra, H.; Bilal, M.; Boiko, D.I.; Tarianyk, K.A.; Alexiou, A. Roles of Clock Genes in the Pathogenesis of Parkinson’s Disease. Ageing Res. Rev. 2022, 74, 101554. [Google Scholar] [PubMed]
  5. Imenshahidi, M.; Karimi, G.; Hosseinzadeh, H. Effects of melatonin on cardiovascular risk factors and metabolic syndrome: A comprehensive review. NaunynSchmiedebergs Arch. Pharmacol. 2020, 393, 521–536. [Google Scholar]
  6. Peuhkuri, K.; Sihvola, N.; Korpela, R. Dietary factors and fluctuating levels of melatonin. Food Nutr. Res. 2012, 56. [Google Scholar] [CrossRef] [Green Version]
  7. Belikova, O.I.; Cherno, V.S.; Frenkel, Y.D.; Kostenko, V.O. Influence of chronic hypomelatoninemia on carbohydrate and lipid metabolism of rats kept on “Western pattern diet”. Fiziol. Zh. 2018, 64, 52–60. [Google Scholar] [CrossRef] [Green Version]
  8. Belikova, E.I.; Frenkel, Y.D.; Cherno, V.S. Influence of exogenous melatonin on free radical processes in rats exposed to light around the clock under modeling of insulin resistance syndrome. Mod. Probl. Hyg. Radiat. Environ. Med. 2017, 7, 35–51. [Google Scholar]
  9. Belikova, O.I.; Frenkel, Y.D.; Cherno, V.S.; Kostenko, V.O. Influence of nuclear factor κB inhibitor on biochemical markers of insulin resistance syndrome under hypopinealism and high-calorie carbohydrate-lipid diet. World Med. Biol. 2017, 3, 80–82. [Google Scholar] [CrossRef]
  10. Frenkel, Y.D.; Cherno, V.S.; Kostenko, V.O. Nrf2 induction alleviates metabolic disorder and systemic inflammatory response in rats under a round-the-clock lighting and high-carbohydrate-lipid diet. Rom. J. Diabetes Nutr. Metab. Dis. 2022, 29, 194–201. [Google Scholar]
  11. Yelins’ka, A.M.; Shvaykovs’ka, O.O.; Kostenko, V.O. Epigallocatechin-3-gallate prevents disruption of connective tissue in periodontium and salivary glands of rats during systemic inflammation. Wiad. Lek. 2018, 71, 869–873. [Google Scholar]
  12. Kozaeva, R.; Klymenko, M.O.; Katrushov, O.V.; Kostenko, V.O. Bioflavonoids as agents for correcting nitro-oxidative stress and salivary gland functions in rats exposed to alcohol during modeled lipopolysaccharide-induced systemic inflammatory response. Wiad. Lek. 2022, 75, 685–690. [Google Scholar] [CrossRef] [PubMed]
  13. Yelins’ka, A.M.; Liashenko, L.I.; Kostenko, V.O. Quercetin potentiates antiradical properties of epigallocatechin-3-gallate in periodontium of rats under systemic and local administration of lipopolisaccharide of Salmonella typhi. Wiad. Lek. 2019, 72, 1499–1503. [Google Scholar] [CrossRef] [PubMed]
  14. Yavtushenko, I.V.; Nazarenko, S.M.; Katrushov, O.V.; Kostenko, V.O. Quercetin limits the progression of oxidative and nitrosative stress in the rats’ tissues after experimental traumatic brain injury. Wiad. Lek. 2020, 73, 2127–2132. [Google Scholar] [CrossRef] [PubMed]
  15. Zhu, X.; Liu, Q.; Wang, M.; Liang, M.; Yang, X.; Xu, X.; Zou, H.; Qiu, J. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS ONE 2011, 6, e27081. [Google Scholar] [CrossRef] [PubMed]
  16. Farkhondeh, T.; Folgado, S.L.; Pourbagher-Shahri, A.M.; Ashrafizadeh, M.; Samarghandian, S. The therapeutic effect of resveratrol: Focusing on the Nrf2 signalling pathway. Biomed. Pharmacother. 2020, 127, 110234. [Google Scholar] [CrossRef]
  17. Chekalina, N.I.; Kazakov, Y.M.; Mamontova, T.V.; Vesnina, L.E.; Kaidashev, I.P. Resveratrol more effectively than quercetin reduces endothelium degeneration and level of necrosis factor α in patients with coronary artery disease. Wiad. Lek. 2016, 69, 475–479. [Google Scholar] [PubMed]
  18. Akgun-Unal, N.; Ozyildirim, S.; Unal, O.; Gulbahce-Mutlu, E.; Mogulkoc, R.; Baltaci, A.K. The effects of resveratrol and melatonin on biochemical and molecular parameters in diabetic old female rat hearts. Exp. Gerontol. 2023, 172, 112043. [Google Scholar] [CrossRef] [PubMed]
  19. Shen, Y.; Endale, M.; Wang, W.; Morris, A.R.; Francey, L.J.; Harold, R.L.; Hammers, D.W.; Huo, Z.; Partch, C.L.; Hogenesch, J.B.; et al. NF-κB modifies the mammalian circadian clock through interaction with the core clock protein BMAL1. PLoS Genet. 2021, 17, e1009933. [Google Scholar] [CrossRef] [PubMed]
  20. Wible, R.S.; Ramanathan, C.; Sutter, C.H.; Olesen, K.M.; Kensler, T.W.; Liu, A.C.; Sutter, T.R. NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus. eLife 2018, 7, e31656. [Google Scholar] [CrossRef]
  21. Mozafari, M.; Nekooeian, A.A.; Panjeshahin, M.R.; Zare, H.R. The effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension: A study of antihypertensive mechanisms. Iran J. Med. Sci. 2015, 40, 152–160. [Google Scholar] [PubMed]
  22. Vesely, O.; Baldovska, S.; Kolesarova, A. Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids. Nutrients 2021, 13, 3095. [Google Scholar] [CrossRef] [PubMed]
  23. Frenkel, Y.D.; Zyuzin, V.O.; Cherno, V.S.; Kostenko, V.O. Effect of epigallocatechin-3-gallate and quercetin on the production of reactive oxygen and nitrogen species in liver of rats exposed to round-the-clock light and kept on carbohydrate-lipid diet. Fiziol. Zh. 2022, 68, 20–27. [Google Scholar] [CrossRef]
  24. Akimov, O.Y.; Kostenko, V.O. Oxidative-Nitrosative Stress and Methods of Its Research; Mahnoliya: Lviv, Ukraine; p. 152p.
  25. Chao, P.C.; Li, Y.; Chang, C.H.; Shieh, J.P.; Cheng, J.T.; Cheng, K.C. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes. Biomed. Pharmacother. 2018, 101, 155–161. [Google Scholar] [CrossRef]
  26. Poulose, N.; Raju, R. Sirtuin regulation in aging and injury. Biochim. Biophys. Acta 2015, 1852, 2442–2455. [Google Scholar] [CrossRef] [Green Version]
  27. Markus, R.P.; Cecon, E.; Pires-Lapa, M.A. Immune-pineal axis: Nuclear factor κB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells. Int. J. Mol. Sci. 2013, 14, 10979–10997. [Google Scholar] [CrossRef] [Green Version]
  28. Wang, Y.; Qi, W.; Song, G.; Pang, S.; Peng, Z.; Li, Y.; Wang, P. High-Fructose Diet Increases Inflammatory Cytokines and Alters Gut Microbiota Composition in Rats. Mediators Inflamm. 2020, 2020, 6672636. [Google Scholar] [CrossRef]
  29. Duan, Y.; Zeng, L.; Zheng, C.; Song, B.; Li, F.; Kong, X.; Xu, K. Inflammatory Links Between High Fat Diets and Diseases. Front. Immunol. 2018, 9, 2649. [Google Scholar] [CrossRef] [Green Version]
  30. Wang, X.; Zhang, D.M.; Gu, T.T.; Ding, X.Q.; Fan, C.Y.; Zhu, Q.; Shi, Y.W.; Hong, Y.; Kong, L.D. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signalling pathway. Biochem. Pharmacol. 2013, 86, 1791–1804. [Google Scholar] [CrossRef]
  31. Vieira, E.; Mirizio, G.G.; Barin, G.R.; de Andrade, R.V.; Nimer, N.F.S.; La Sala, L. Clock Genes, Inflammation and the Immune System-Implications for Diabetes, Obesity and Neurodegenerative Diseases. Int. J. Mol. Sci. 2020, 21, 9743. [Google Scholar] [CrossRef]
  32. Ojetola, A.A.; Asiwe, J.N.; Adeyemi, W.J.; Ogundipe, D.J.; Fasanmade, A.A. Dietary Supplementation with D-Ribose-L-Cysteine Prevents Hepatic Stress and Pro-Inflammatory Responses in Male Wistar Rats Fed a High-Fructose High-Fat Diet. Pathophysiology 2022, 29, 631–639. [Google Scholar] [CrossRef] [PubMed]
  33. Boiko, D.I.; Shkodina, A.D.; Hasan, M.M.; Bardhan, M.; Kazmi, S.K.; Chopra, H.; Bhutra, P.; Baig, A.A.; Skrypnikov, A.M. Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression. Neurochem. Res. 2022, 47, 2909–2924. [Google Scholar] [CrossRef] [PubMed]
  34. Koushki, M.; Dashatan, N.A.; Meshkani, R. Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin. Ther. 2018, 40, 1180–1192.e5. [Google Scholar] [CrossRef] [PubMed]
  35. Kopec, A.; Piatkowska, E.; Leszczynska, T.; Koronowicz, A. Effect of long term administration of resveratrol on lipid concentration in selected organs and liver’s histology in rats fed high fructose diet. J. Funct. Foods 2013, 5, 299–305. [Google Scholar] [CrossRef]
  36. Reda, D.; Elshopakey, G.E.; Mahgoub, H.A.; Risha, E.F.; Khan, A.A.; Rajab, B.S.; El-Boshy, M.E.; Abdelhamid, F.M. Effects of Resveratrol Against Induced Metabolic Syndrome in Rats: Role of Oxidative Stress, Inflammation, and Insulin Resistance. Evid. Based Complement. Alternat. Med. 2022, 2022, 3362005. [Google Scholar] [CrossRef] [PubMed]
  37. Kuršvietienė, L.; Stanevičienė, I.; Mongirdienė, A.; Bernatonienė, J. Multiplicity of effects and health benefits of resveratrol. Medicina 2016, 52, 148–155. [Google Scholar] [CrossRef] [PubMed]
  38. Javkhedkar, A.A.; Quiroz, Y.; Rodriguez-Iturbe, B.; Vaziri, N.D.; Lokhandwala, M.F.; Banday, A.A. Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2015, 308, R840–R846. [Google Scholar] [CrossRef] [Green Version]
  39. Kuznetsova, T.Y.; Solovyova, N.V.; Solovyov, V.V.; Kostenko, V.O. Antioxidant activity of melatonin and glutathione interacting with hydroxyl and superoxide anion radicals. Ukr. Biochem. J. 2017, 89, 22–30. [Google Scholar] [CrossRef] [Green Version]
  40. Abadi, S.H.M.H.; Shirazi, A.; Alizadeh, A.M.; Changizi, V.; Najafi, M.; Khalighfard, S.; Nosrati, H. The Effect of Melatonin on Superoxide Dismutase and Glutathione Peroxidase Activity, and Malondialdehyde Levels in the Targeted and the Non-targetedLung and Heart Tissues after Irradiation in Xenograft Mice Colon Cancer. Curr. Mol. Pharmacol. 2018, 11, 326–335. [Google Scholar] [CrossRef]
  41. Sun, L.; Wang, Y.; Song, Y.; Cheng, X.R.; Xia, S.; Rahman, M.R.; Shi, Y.; Le, G. Resveratrol restores the circadian rhythmic disorder of lipid metabolism induced by high-fat diet in mice. Biochem. Biophys. Res. Commun. 2015, 458, 86–91. [Google Scholar] [CrossRef]
Pathophysiology 30 00005 g001 550
Figure 1. Serum Melatonin, n = 7. Values were expressed as Mean ± SEM. Control, HFHLD (high-fructose high-lipid diet) + RCL (round-the-clock lighting), and HFHLD + RCL + Resveratrol; ** p < 0.001 is significant compared to group 1; ## p < 0.001 is significant compared to group 2.
Figure 1. Serum Melatonin, n = 7. Values were expressed as Mean ± SEM. Control, HFHLD (high-fructose high-lipid diet) + RCL (round-the-clock lighting), and HFHLD + RCL + Resveratrol; ** p < 0.001 is significant compared to group 1; ## p < 0.001 is significant compared to group 2.
Pathophysiology 30 00005 g001
Table
Table 1. Components and contents in standard and high-lipid diet.
Table 1. Components and contents in standard and high-lipid diet.
Standard Rat ChowHigh-Lipid Diet
Nutrients g/kg Total Nutrients g/kg Total
Protein160Protein94
Fat70Fat313
Carbohydrate480Carbohydrate466
Fibre68Fibre14
Sodium2.7Sodium4
Vitaminand mineral mix36Vitaminand mineral mix40
Ingredients:
Refined wheat flour450
Skimmed milk powder200
Table margarine 82% fat200
Starch100
Peroxidised sunflower oil40
Sodium chloride10
Total calorie2720 kcal/kgTotal calorie4477 kcal/kg
Table
Table 2. Effects of resveratrol on the systemic inflammatory response indices in the serum of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Table 2. Effects of resveratrol on the systemic inflammatory response indices in the serum of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Groups/ParametersTNF-α
(pg/mL)		CRP
(ng/mL)
1. Group 1 (Control), n = 734.0 ± 2.04.1 ± 0.1
2. Group 2 (HFHLD + RCL), n = 7109.8 ± 6.0 **12.8 ± 0.3 **
3. Group 3 (HFHLD + RCL + Resveratrol), n = 743.6 ± 4.9 ##5.3 ± 0.3 *,##
Note: The table represents the mean ± SEM; * p < 0.01, and ** p < 0.001 is significant compared to group 1; ## p < 0.001 is significant compared to group 2; TNF-α—Tumour necrosis factor-alpha; CRP—C-reactive protein.
Table
Table 3. Effects of resveratrol on lipid peroxidation (LPO) in the blood of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Table 3. Effects of resveratrol on lipid peroxidation (LPO) in the blood of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Groups/ParametersMDA-TBA2
(µmol/L)
Before
Incubation		After
Incubation		Increment over
Incubation Time
1. Group 1 (Control), n = 711.2 ± 0.925.4 ± 2.014.2 ± 2.4
2. Group 2 (HFHLD + RCL), n = 723.0 ± 0.6 **48.3 ± 2.1 **25.3 ± 1.9 *
3. Group 3 (HFHLD + RCL + Resveratrol), n = 712.6 ± 0.9 ##27.7 ± 1.9 ##15.1 ± 2.2 #
Note: The table represents the mean ± SEM; * p < 0.01, and ** p < 0.001 is significant compared to group 1; # p < 0.01, and ## p < 0.001 is significant compared to group 2; MDA-TBA2—Malondialdehyde—thiobarbituric acid adducts.
Table
Table 4. Effects of resveratrol on carbohydrate metabolism in the serum of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Table 4. Effects of resveratrol on carbohydrate metabolism in the serum of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Groups/ParametersGlucose
(mmol/L)		Insulin
(μU/mL)		HOMA-IR
1. Group 1 (Control), n = 74.94 ± 0.241.5 ± 0.20.32 ± 0.06
2. Group 2 (HFHLD + RCL), n = 76.89 ± 0.25 *5.5 ± 0.2 **1.17 ± 0.04 **
3. Group 3 (HFHLD + RCL + Resveratrol), n = 74.45 ± 0.18 #2.1 ± 0.1 ##0.42 ± 0.03 ##
Note: The table represents the mean ± SEM; * p < 0.01, and ** p < 0.001 is significant compared to group 1; # p < 0.01, and ## p < 0.001 is significant compared to group 2; HOMA-IR—Homeostasis Model Assessment of Insulin Resistance.
Table
Table 5. Effects of resveratrol on lipid profile in the serum of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Table 5. Effects of resveratrol on lipid profile in the serum of rats fed a high-fructose high-lipid diet (HFHLD) under round-the-clock lighting (RCL).
Groups/ParametersTotal CH
(mmol/L)		HDL
(mmol/L)		LDL
(mmol/L)		VLDL
(mmol/L)		TAG
(mmol/L)
1. Group 1 (Control), n = 72.39 ± 0.290.63 ± 0.041.47 ± 0.290.29 ± 0.020.65 ± 0.05
2. Group 2 (HFHLD + RCL), n = 72.62 ± 0.300.23 ± 0.02 **1.43 ± 0.290.96 ± 0.04 **2.10 ± 0.10 **
3. Group 3 (HFHLD + RCL + Resveratrol), n = 72.28 ± 0.220.48 ± 0.02 *,#1.29 ± 0.220.51 ± 0.03 **,##1.11 ± 0.06 **,##
Note: The table represents the mean ± SEM; * p < 0.01, and ** p < 0.001 is significant compared to group 1; # p < 0.01, and ## p < 0.001 is significant compared to group 2; CH—Cholesterol; HDL—High-density lipoprotein; LDL—Low-density lipoprotein; VLDL—Very low-density lipoprotein; TAGs—Triacylglycerol.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Frenkel, Y.; Cherno, V.; Kostenko, H.; Chopra, H.; Gautam, R.K.; Kostenko, V. Dietary Supplementation with Resveratrol Attenuates Serum Melatonin Level, Pro-Inflammatory Response and Metabolic Disorder in Rats Fed High-Fructose High-Lipid Diet under Round-the-Clock Lighting. Pathophysiology 2023, 30, 37-47. https://doi.org/10.3390/pathophysiology30010005

AMA Style

Frenkel Y, Cherno V, Kostenko H, Chopra H, Gautam RK, Kostenko V. Dietary Supplementation with Resveratrol Attenuates Serum Melatonin Level, Pro-Inflammatory Response and Metabolic Disorder in Rats Fed High-Fructose High-Lipid Diet under Round-the-Clock Lighting. Pathophysiology. 2023; 30(1):37-47. https://doi.org/10.3390/pathophysiology30010005

Chicago/Turabian Style

Frenkel, Yurii, Valerii Cherno, Heorhii Kostenko, Hitesh Chopra, Rupesh K. Gautam, and Vitalii Kostenko. 2023. "Dietary Supplementation with Resveratrol Attenuates Serum Melatonin Level, Pro-Inflammatory Response and Metabolic Disorder in Rats Fed High-Fructose High-Lipid Diet under Round-the-Clock Lighting" Pathophysiology 30, no. 1: 37-47. https://doi.org/10.3390/pathophysiology30010005

Article Metrics

Back to TopTop